Sweden gives green light to Nobel Biocare
The Swedish Medical Products Agency (SMPA) has said that Nobel Biocare can continue to market its dental implants NobelDirect and NobelPerfect - albeit with certain restrictions.
In order to continue sales, the group will have to adjust its information policy regarding the products, the SMPA said, following an investigation into the company's product.
"The investigation showed that there can be shortcomings in the instructions for use, something that can explain the raised risk for breakdown of the jawbone that has been observed for the dental implants." the Swedish health said.
It added that Noble Biocare will have to submit a plan for clarifying the relevant details in its informational materials by January 8th or face a possible ban of the product from the Swedish market.
The investigation into NobelDirect was first prompted in May 2005, after two Swedish dentists alleged that the product caused unexpected bone loss.
Comments
See Also
In order to continue sales, the group will have to adjust its information policy regarding the products, the SMPA said, following an investigation into the company's product.
"The investigation showed that there can be shortcomings in the instructions for use, something that can explain the raised risk for breakdown of the jawbone that has been observed for the dental implants." the Swedish health said.
It added that Noble Biocare will have to submit a plan for clarifying the relevant details in its informational materials by January 8th or face a possible ban of the product from the Swedish market.
The investigation into NobelDirect was first prompted in May 2005, after two Swedish dentists alleged that the product caused unexpected bone loss.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.